Polo-like kinase 1 as a potential therapeutic target and prognostic factor for various human malignancies: A systematic review and meta-analysis.

Wang, Ming-Wen; Li, Zhong; Chen, Li-Hong; Wang, Ning; Hu, Jian-Ming; Du, Jin; Pang, Li-Juan; Qi, Yan

Wang, Ming-Wen; Li, Zhong; Chen, Li-Hong; Wang, Ning; Hu, Jian-Ming; Du, Jin; Pang, Li-Juan; Qi, Yan.

Afiliação

Wang MW; Department of Pathology, The First Affiliated Hospital to Shihezi University School of Medicine, School of Medicine, Shihezi University, Shihezi, China.
Li Z; Department of Pathology, The First Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, China.
Chen LH; Department of Pathology, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, China.
Wang N; Department of Pathology, The First Affiliated Hospital to Shihezi University School of Medicine, School of Medicine, Shihezi University, Shihezi, China.
Hu JM; Department of Pathology, The First Affiliated Hospital to Shihezi University School of Medicine, School of Medicine, Shihezi University, Shihezi, China.
Du J; Department of Pathology, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, China.
Pang LJ; Department of Pathology, The First Affiliated Hospital to Shihezi University School of Medicine, School of Medicine, Shihezi University, Shihezi, China.
Qi Y; Department of Pathology, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, China.

Front Oncol ; 12: 917366, 2022.

Article em En | MEDLINE | ID: mdl-36457496

Palavras-chave

PLK-1; malignant neoplasm; meta-analysis; prognosis; survival

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google